Mechanisms to help identify proposals offering the best value for money, 2020

Keyword(s):  
2018 ◽  
Vol 11 (1) ◽  
pp. 72-82
Author(s):  
Kariyoto Kariyoto

Pengukuran organisasi sektor publik menjadi penting untuk mengetahui tingkat pencapain pelayanan kepada masyarakat. Kinerja organisasi sektor publik dapat diukur menggunakan alat dan indikator yang sesuai. Tujuan dari penelitian ini adalah untuk mengetahui konsep nilai waktu uang, masukan keluaran hasil, nilai terbaik sebagai indikator pengukuran kinerja sektor publik. Penelitian ini berlokasi di Perpustakaan Universitas Brawijaya Malang. Jenis penelitian melalui studi perpustakaan. Pengumpulan data dilakukan dengan observasi dan dokumentasi buku yang berhubungan dengan kinerja organisasi sektor publik. Analisis data digunakan reduksi data, penyajian data, dan penarikan kesimpulan atau verifikasi data. Hasil penelitian menunjukkan bahwa nilai waktu uang, masukan keluaran hasil dan nilai terbaik dapat dipakai sebagai alat pengukuran kinerja organisasi sektor publik.


2020 ◽  
Vol 20 (2) ◽  
pp. 192-214
Author(s):  
Hana Kováčiková ◽  
Ondrej Blažo

Summary A public procurement should be an effective tool through which public authorities shall spend public finances sparingly. With modernisation of this area of law in 2014, a new concept of bids evaluation came forward – a value for money. Now it is more important than any time before to ensure fair tenders to be submitted during the procurement. It is a well-known fact, that only a true competition between the bidders decreases the prices and raises the quality of their bids. But how contracting authorities deal with these goals while procuring without competition? This article analyses limited tendering with focus on extreme urgency. Authors try to give an answer to the question, which attribute of this procedure prevails – its flexible use in extraordinary situations or its interfering effect to value for money achievement.which makes Slovakia open to severe criticism from international human rights bodies.


2018 ◽  
Vol 10 (2) ◽  
pp. 752
Author(s):  
Pablo Zapatero Miguel ◽  
Marc Petz

Abstract: The revised Government Procurement Agreement (GPA) illustrates the long-term trans­formation in the way governments currently deliver public policies: steering, not rowing. Under a re­gulatory paradigm based on improving efficiency and best value for money, the 51 GPA Parties have reformed the previous GPA framework and expanded global procurement markets in accordance. Howe­ver, the figures of this structural policy trend have not yet been properly mapped. This research estima­tes on basis of the available data that the GPA parties cover round 26% (US$2,140bn) of their GGCE (US$8,220bn), whereby the global GPA coverage could potentially be expanded substantially (compare to global GGCE: US$13,100bn) on the long term.Keywords: public-private partnerships, world trade, market-formation, government procurement, GPA.Resumen: El Acuerdo de Contratación Pública (GPA) revisado ilustra la transformación de largo plazo en la forma en que los Estados desarrollan políticas públicas: guiar, y no remar. Bajo un paradigma regulatorio basado en la mejora de la eficiencia y el mejor valor por el dinero, los 51 Miembros del GPA revisado han reformado el marco legal originario y contribuido a expandir los emergentes mercados glo­bales de contratación pública. Esta investigación calcula en base a los datos disponibles que las partes del GPA cubren un 26% (2.140.000 US$) de su GGCE (8.220.000 US$), mientras la cobertura global del GPA podría expandirse de manera significativa (comparar con el GGCE global: 13.100.000 US$) a largo plazo.Palabras clave: partenariados público-privados, comercio mundial, formación de mercados, con­tratación pública, GPA.


2021 ◽  
Vol 12 ◽  
Author(s):  
Entela Xoxi ◽  
Karen M Facey ◽  
Americo Cicchetti

Italy has a well-established prominent system of national registries to support managed entry agreements (MEAs), monitoring innovative medicinal products (MPs) with clinical as well as economic uncertainties to ensure appropriate use and best value for money. The technological architecture of the registries is funded by pharmaceutical companies, but fully governed by the national medicines agency (AIFA). A desktop analysis was undertaken of data over a 15-year timeframe of all AIFA indication-based registries and associated EMA information. The characteristics of registries were evaluated, comparing orphan MPs vs. all MPs exploring cancer and non-cancer indications. OMP (orphan medicinal product) registries’ type vs. AIFA innovation status and EMA approval was reviewed. Of the 283 registries, 182 are appropriateness registries (35.2% relate to OMPs, with an almost equal split of cancer vs. non-cancer for OMPs and MPs), 35 include financial-based agreements [20% OMPs (2 non-cancer, 5 cancer)], and 60 registries are payment by result agreements [23.3% OMPs (4 non-cancer, 10 cancer)]. Most OMPs (53/88) came through the normal regulatory route. With the strengthening of the system for evaluation of innovation, fewer outcomes-based registries have been instigated. AIFA has overcome many of the challenges experienced with MEA through developing an integrated national web-based data collection system: the challenge that remains for AIFA is to move from using the system for individual patient decisions about treatment to reviewing the wealth of data it now holds to optimize healthcare.


Sign in / Sign up

Export Citation Format

Share Document